You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 1726 to 1750 of about 5880
Next 25
01/19/2016
Neurosurgeons Evaluate Precision Laser Treatment Of Brain Tumors at UC San Diego Health
01/07/2016
Oncurious NV Announces FDA Acceptance of Investigational New Drug (IND) Application for a Phase I/IIa Study with TB-403 for the Treatment of Pediatric Brain Tumors
01/06/2016
Novocure Files Premarket Approval Supplement Application With FDA for Second Generation Optune System
01/05/2016
Intra-arterial administration improves temozolomide delivery and efficacy in a model of intracerebral metastasis, but has unexpected brain toxicity.
Association between human cytomegalovirus infection and histone acetylation level in various histological types of glioma.
Time to use a dose of Chloroquine as an adjuvant to anti-cancer chemotherapies.
01/04/2016
SPAGNOLETTI & ASSOCIATES RAISING FUNDS FOR MUSELLA FOUNDATION
01/03/2016
Florida Brain Tumor Associations ` 1st Annual Gala
12/31/2015
Added a nice survivor story with a picture of a nice lady wearing the Optune device. In 1 photo she shows it off, in the other she hides it.
12/24/2015
The Musella Foundation has awarded another pediatric brain tumor research grant
12/23/2015
Study Finds Mechanism That Causes Normal Cells to Become Cancerous
12/21/2015
Recurrent venous thromboembolism in glioblastoma.
12/20/2015
IBTA Newsletter
12/19/2015
Brain cancer patient beats odds with experimental treatment
12/15/2015
Experimental drugs that change energy supply in cells could slow brain tumor growth
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma
12/14/2015
New Data on Tumor Treating Fields’ Anti-Mitotic Mechanism of Action Published in Scientific Reports
Roche`s Alecensa Granted Accelerated FDA Approval in Lung Cancer
12/13/2015
Patient with Brain Tumor Responds Dramatically to Targeted Therapy
12/12/2015
The Musella Foundation has awarded a pediatric brain tumor research grant
A phase II trial of enzastaurin (LY317615) in combination with bevacizumab in adults with recurrent malignant gliomas.
First Patient Enrolled in Toca 5, Tocagen’s Phase 2/3 Clinical Trial in Patients with Recurrent Glioblastoma or Anaplastic Astrocytoma
12/08/2015
Novocure (NVCR) Issues Positive Update on TTFields Study in Certain Glioblastoma Patients
11/27/2015
Existing Drug May Limit Recurrence and Metastasis of Glioblastoma Multiforme
Experimental brain cancer treatment offers family hope